Endometriosis Trial, Recruiting (NCT07711743)

Endometriosis Trial, Recruiting NCT07711743 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT07711743 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women between 18 and 40 years old.
People who have been recommended surgery for an ovarian endometrioma (a cyst on the ovary caused by endometriosis) based on symptoms and/or scan results.
People with an ovarian endometrioma of at least 3 cm in size, confirmed by an ultrasound and/or MRI scan before surgery.
People whose planned surgery involves a laparoscopic cystectomy (keyhole surgery to remove the cyst).
People who have given written agreement to take part in the trial.

Who may not be able to join:

People who may have difficulty following the study procedures or understanding what is involved.
People who have previously had surgery on the affected ovary.
People whose ovarian endometrioma has come back after a previous diagnosis (a recurrence).
People who are currently pregnant or breastfeeding.
People who are already taking part in another clinical trial that could affect the results of this study, such as trials that may influence hormone levels or pregnancy outcomes.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41 31 63 2 12 01

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07711743

Sponsor: Insel Gruppe AG, University Hospital Bern

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

Trial contact: +41 31 63 2 12 01

More information: https://clinicaltrials.gov/study/NCT07711743

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women between 18 and 40 years old.
People who have been recommended surgery for an ovarian endometrioma (a cyst on the ovary caused by endometriosis) based on symptoms and/or scan results.
People with an ovarian endometrioma of at least 3 cm in size, confirmed by an ultrasound and/or MRI scan before surgery.
People whose planned surgery involves a laparoscopic cystectomy (keyhole surgery to remove the cyst).
People who have given written agreement to take part in the trial.

Who may not be able to join:

People who may have difficulty following the study procedures or understanding what is involved.
People who have previously had surgery on the affected ovary.
People whose ovarian endometrioma has come back after a previous diagnosis (a recurrence).
People who are currently pregnant or breastfeeding.
People who are already taking part in another clinical trial that could affect the results of this study, such as trials that may influence hormone levels or pregnancy outcomes.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Insel Gruppe AG, University Hospital Bern

Registry

ClinicalTrials.gov

Start date

9 July 2026

Est. completion

7 July 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Depth of thermal tissue effects in the ovarian endometrioma cyst wall

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov